August 20, 2021 (Newswire.com) –
Swiss Life Sciences Group Plc (SLSG) is happy to announce its partnership with Switzerland’s main hashish and CBD genetics consultants, Bio Zu Farm, who’ve been creating their very own hashish genetics for greater than 25 years. Bio Zu at the moment are the house owners of main hashish strains similar to BZ1, one in every of Europe’s hottest strains, which is being broadly grown in each EU nation and loved by hundreds of thousands of shoppers globally.
SLSG and its Swiss subsidiary, Savim SA, are creating particular proprietary strains of hashish, with a deal with varied areas, however significantly on future medical remedies for quite a lot of sicknesses and ailments, together with epilepsy, autism, and the completely different phases of COVID-19. The goal is to develop genetics that completely match the terpene profiles, THC ranges and CBD ranges which can be already being efficiently utilized in remedies, and enhance on them with elite genetics. SLSG’s goal is to make out there globally a number of proprietary medical hashish strains and related medical remedies, with irrefutable monitoring and integrity, from genetics to finish product.
Bio Zu Farm can also be managing the set-up and operation of Swiss Life Sciences Group’s state-of-the-art, managed surroundings manufacturing facility in Switzerland. This facility makes use of the very newest in superior propagation methods and blockchain administration expertise to ship premium pharmaceutical-grade proprietary strains of hashish to the CBD healthcare and medical industries.
Matteo Ambrosini, COO of Bio Zu Farm: “We’re very excited to be working with Swiss Life Sciences Group and the staff at Savim SA to convey our expertise and experience within the area of cannabis-related genetics to the broader shopper market. This suits with our personal robust values and business goals. The group’s goal to construct from the bottom up, by creating their very own strains of hashish genetics, is refreshing within the hashish trade. Taking a look at what’s already on the market and making it higher and extra broadly out there has at all times been one thing we admire. The eye to element we’re taking within the set-up and operation of the manufacturing facility is guided by SLSG, to guarantee that we might be on the chopping fringe of the trade. Striving for technical excellence and innovation at each stage is our aim.”
JP Engele, COO of Savim SA: “We’ve spent over two years finishing up a lot granular analysis, each vertically and horizontally, in selecting the partnerships that we wish to have right here in Switzerland. There are various seed producers, however none of them include the pedigree of genetics experience and integrity of Bio Zu Farm. Each Matteo and President and Founder Davis Ramelli, are consummate professionals and genuinely care about shifting this trade from a ‘gray space’ to being clearly within the white and clear area of play. This enables everybody to really feel comfy and revel in merchandise that might be life-changing for therefore many. We’ll proceed to type partnerships right here in Switzerland, and are very pleased with the mixing we’re attaining and the staff we’re constructing. Arms-down, Bio Zu are the precise companions.”
Boilerplate: At Swiss Life Sciences Group, our major aim is to make a distinction by advancing the analysis, improvement and manufacturing of pure, life-changing supplies we discover in CBD. www.swisslifesciencesgroup.com
PR and Media enquiries: email@example.com
Supply: Swiss Life Sciences Group